Dr. Murray received her Ph.D. from the Department of Pharmacology, Case Western Reserve University and completed a post-doctoral fellowship in Cancer Biology at the University of Texas Medical Branch. Dr. Murray is a Senior Associate Consultant at the Mayo Clinic. Dr. Murray is interested in identifying new therapeutic targets for intervention and treatment of PDAC. To this end, her laboratory investigates the role of atypical protein kinase C (PKC) in the development and maintenance of pancreatic cancer. Dr. Murray received her Ph.D. from the Department of Pharmacology, Case Western Reserve University and completed a post-doctoral fellowship in Cancer Biology at the University of Texas Medical Branch. Dr. Murray is a Senior Associate Consultant at the Mayo Clinic. Dr. Murray is interested in identifying new therapeutic targets for intervention and treatment of PDAC. To this end, her laboratory investigates the role of atypical protein kinase C (PKC) in the development and maintenance of pancreatic cancer.
Gastroenterology